Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

Jason S. McLellan(The University of Texas at Austin), Peter D. Kwong(National Institutes of Health), Ulrich Baxa(National Institutes of Health), Syed M. Moin(National Institutes of Health), Guillaume B. E. Stewart-Jones(Moderna Therapeutics (United States)), Barney S. Graham(National Institutes of Health), Arjen Q. Bakker(AIMM Therapeutics (Netherlands)), Yongping Yang(National Institutes of Health), Jeffrey C. Boyington(National Institutes of Health), Tim Beaumont(AIMM Therapeutics (Netherlands)), Sung‐Youl Ko(National Institutes of Health), Anqi Zheng(Peking University), Michael Joyce(University of Alberta), John-Paul Todd(National Institutes of Health), Cinque Soto(National Institutes of Health), Gwo‐Yu Chuang(Moderna Therapeutics (United States)), Zizheng Zheng(Xiamen University), Ningshao Xia(Xiamen University), Kevin W. Graepel(National Institutes of Health), Sanjay Srivatsan(University of Washington), Hergen Spits(Erasmus MC Cancer Institute), Lei Chen(National Institutes of Health), Man Chen(Shandong Provincial Hospital), Azad Kumar(Siddhartha University), Baoshan Zhang(National Institutes of Health), Mallika Sastry(National Institutes of Health), Srinivas S. Rao(University of Vienna), Tongqing Zhou(National Institutes of Health)
Science
October 31, 2013
Cited by 1,155


Related Papers